(Q40108755)

1 July 2019

title

Noninvasive detection of HER2 amplification with plasma DNA digital PCR. (English)

1 reference

1 July 2019

8

Alan Ashworth

1 reference

1 July 2019

Heidrun Gevensleben

1

1 reference

1 July 2019

Isaac Garcia-Murillas

2

1 reference

1 July 2019

Monika K Graeser

3

1 reference

1 July 2019

Gaia Schiavon

4

1 reference

1 July 2019

Peter Osin

5

1 reference

1 July 2019

Marina Parton

6

1 reference

1 July 2019

Ian E Smith

7

1 reference

1 July 2019

Nicholas C Turner

9

1 reference

1 July 2019

language of work or name

English

0 references

publication date

1 May 2013

1 reference

1 July 2019

published in

Clinical Cancer Research

1 reference

1 July 2019

volume

19

1 reference

1 July 2019

issue

12

1 reference

1 July 2019

page(s)

3276-3284

1 reference

1 July 2019

1 reference

12 December 2020

Counting alleles reveals a connection between chromosome 18q loss and vascular invasion

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

Plasma nucleic acids in the diagnosis and management of malignant disease.

1 reference

12 December 2020

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials

1 reference

12 December 2020

BEAMing up for detection and quantification of rare sequence variants.

1 reference

12 December 2020

BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions

1 reference

12 December 2020

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

12 December 2020

Digital PCR for the molecular detection of fetal chromosomal aneuploidy

1 reference

12 December 2020

Circulating mutant DNA to assess tumor dynamics

1 reference

12 December 2020

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

1 reference

12 December 2020

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer

1 reference

12 December 2020

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

1 reference

12 December 2020

Genome remodelling in a basal-like breast cancer metastasis and xenograft

1 reference

12 December 2020

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

12 December 2020

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

1 reference

12 December 2020

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

1 reference

12 December 2020

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

1 reference

12 December 2020

HER2-positive circulating tumor cells in breast cancer

1 reference

12 December 2020

Detection of HER2 amplification in circulating free DNA in patients with breast cancer.

1 reference

12 December 2020

HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis

1 reference

12 December 2020

PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis

1 reference

12 December 2020

Genomic analysis of circulating cell-free DNA infers breast cancer dormancy

1 reference

12 December 2020

High-throughput droplet digital PCR system for absolute quantitation of DNA copy number

1 reference

12 December 2020

Functional characterization of the 19q12 amplicon in grade III breast cancers

1 reference

12 December 2020

Genetic heterogeneity and cancer drug resistance

1 reference

12 December 2020

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

1 reference

12 December 2020

Comprehensive molecular portraits of human breast tumours

1 reference

12 December 2020

Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing

1 reference

12 December 2020

10.1158/1078-0432.CCR-12-3768

Identifiers

DOI

1 reference

1 July 2019

PMC publication ID

6485473

1 reference

1 July 2019

PubMed publication ID

23637122

1 reference

1 July 2019